Every rating change, initiation and price-target move the sell side published across the equities tracked here, newest first.
Ratings are attributed to the research firm, not to individual analysts. Latest event 15h ago.
| Ticker | Firm | Action | Rating | Target | Date |
|---|---|---|---|---|---|
| PODDInsulet Corporation | Leerink Partners | Downgraded from Outperform | Market Perform | $247 $145 | Aug 6 |
| ISRGIntuitive Surgical, Inc. | Leerink Partners | Maintained | Outperform | $573 $454 | Jul 17 |
| GILDGilead Sciences, Inc. |
Showing the 16 most recent target moves over 90 days.
| Leerink Partners |
| Downgraded from Outperform |
| Market Perform |
| $146 $127 |
| Jul 21 |
| IONSIonis Pharmaceuticals, Inc. | Leerink Partners | Maintained | Outperform | $122 $129 | Jun 25 |
| IONSIonis Pharmaceuticals, Inc. | Leerink Partners | Maintained | Outperform | $114 $122 | Jun 17 |
| ELVElevance Health, Inc. | Leerink Partners | Maintained | Market Perform | $364 $395 | Jul 17 |
| LLYEli Lilly and Company | Leerink Partners | Maintained | Outperform | $1,119 $1,232 | Jun 25 |
| UNHUnitedHealth Group Incorporated | Leerink Partners | Maintained | Outperform | $400 $462 | Jun 17 |
| EWEdwards Lifesciences Corporation | Leerink Partners | Upgraded from Market Perform | Outperform | $87 $101 | Jul 25 |
| BRKRBruker Corporation | Leerink Partners | Maintained | Outperform | $60 $70 | Jul 7 |
| ARWRArrowhead Pharmaceuticals, Inc. | Leerink Partners | Maintained | Market Perform | $61 $72 | Jun 17 |
| INCYIncyte Corporation | Leerink Partners | Maintained | Outperform | $131 $155 | Aug 3 |
| ILMNIllumina, Inc. | Leerink Partners | Maintained | Outperform | $175 $210 | Jul 17 |
| MRKMerck & Co., Inc. | Leerink Partners | Maintained | Outperform | $127 $161 | 20h ago |
| REGNRegeneron Pharmaceuticals, Inc. | Leerink Partners | Maintained | Market Perform | $641 $824 | Aug 17 |
| TXG10x Genomics, Inc. | Leerink Partners | Maintained | Market Perform | $23 $40 | Jul 17 |